Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report

Blumendeller, Carolin; Boehme, Julius; Frick, Maximilian; Schulze, Martin; Rinckleb, Antje; Kyzirakos, Christina; Kayser, Simone; Kopp, Maria; Kelkenberg, Sabine; Pieper, Natalia; Bartsch, Oliver; Hadaschick, Dirk; Battke, Florian; Stenzl, Arnulf; Biskup, Saskia

dc.contributor.author	Stenzl, Arnulf
dc.date.accessioned	2021-09-17T10:00:51Z
dc.date.available	2021-09-17T10:00:51Z
dc.date.issued	2021
dc.identifier.issn	2051-1426
dc.identifier.uri	http://hdl.handle.net/10900/119046
dc.language.iso	en	en
dc.publisher	Bmj Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1136/jitc-2020-001406
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210512015105_01447
utue.personen.roh	Blumendeller, Carolin
utue.personen.roh	Boehme, Julius
utue.personen.roh	Frick, Maximilian
utue.personen.roh	Schulze, Martin
utue.personen.roh	Rinckleb, Antje
utue.personen.roh	Kyzirakos, Christina
utue.personen.roh	Kayser, Simone
utue.personen.roh	Kopp, Maria
utue.personen.roh	Kelkenberg, Sabine
utue.personen.roh	Pieper, Natalia
utue.personen.roh	Bartsch, Oliver
utue.personen.roh	Hadaschick, Dirk
utue.personen.roh	Battke, Florian
utue.personen.roh	Stenzl, Arnulf
utue.personen.roh	Biskup, Saskia
dcterms.isPartOf.ZSTitelID	Journal For Immunotherapy of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	Article e001406	de_DE
dcterms.isPartOf.ZS-Volume	9	de_DE
utue.fakultaet	04 Medizinische Fakultät